News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

March 22, 2025
March 22, 2025
Categories

The March 2025 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
March 17, 2025
March 17, 2025
Categories

Stem cell transplant may not be necessary in first remission for patients with mantle cell lymphoma and undetectable MRD (features EA4151)

Do you like it?
Read more
March 6, 2025
March 6, 2025
Categories

Attention CRAs: Travel funds are available for the Spring 2025 Group Meeting (apply now)

Do you like it?
Read more
March 5, 2025
March 5, 2025
Categories

WATCH: Dr. Kathy Miller on how the PATINA trial (AFT-38/PrE0111) shifts the paradigm in HER2+/ER- breast cancer treatment

Do you like it?
Read more
March 5, 2025
March 5, 2025
Categories

Attention APPs: Travel funds are available for the Spring 2025 Group Meeting (apply now)

Do you like it?
Read more
March 5, 2025
March 5, 2025
Categories

Attention radiation oncologists and trainees: Travel funds are available for the Spring 2025 Group Meeting (apply now)

Do you like it?
Read more
March 5, 2025
March 5, 2025
Categories

LISTEN: A JAMA Network Learning podcast interview with Dr. Anand Jillella, author of the newly published results of study EA9131 in JAMA Oncology

Do you like it?
Read more
February 25, 2025
February 25, 2025
Categories

Top trial results of 2024: A year of significant advancements in cancer treatment by ECOG-ACRIN and PrECOG

Do you like it?
Read more
February 25, 2025
February 25, 2025
Categories

The February 2025 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
February 20, 2025
February 20, 2025
Categories

A statement from the cooperative groups

Do you like it?
Read more
February 14, 2025
February 14, 2025
Categories

From the group co-chairs of ECOG-ACRIN: A perspective on indirect costs (requires subscription)

Do you like it?
Read more
February 6, 2025
February 6, 2025
Categories

“I was delighted when I saw the results. Positive phase 3 trials in glioma are a rarity.” David Schiff on the results of E3F05

Do you like it?
Read more
January 17, 2025
January 17, 2025
Categories

The Winter 2025 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
January 16, 2025
January 16, 2025
Categories

Major breast cancer screening trial hits enrollment goal (features TMIST)

Do you like it?
Read more
January 16, 2025
January 16, 2025
Categories

TMIST breast cancer screening trial reaches enrollment milestone, advancing precision screening techniques

Do you like it?
Read more
January 15, 2025
January 15, 2025
Categories

Press Release: Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screening

Do you like it?
Read more
January 14, 2025
January 14, 2025
Categories

Cellular therapies and novel targeted agents will shape the future of acute lymphoblastic leukemia management (mentions E1910)

Do you like it?
Read more
January 10, 2025
January 10, 2025
Categories

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

Do you like it?
Read more
January 8, 2025
January 8, 2025
Categories

WATCH: A recent FDA approval of blinatumomab was supported by data from the E1910 trial

Do you like it?
Read more
January 8, 2025
January 8, 2025
Categories

Active monitoring is promising for women with low-risk ductal carcinoma in situ (features E5194)

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Blood cancer Brain Cancer Breast cancer Cancer screening Cancer treatment Chemotherapy Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing GI cancer Group meeting Head and neck cancer Health equity Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma NCI-MATCH Non-Hodgkin lymphoma Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Social determinants of health (SDoH) Survivorship Targeted therapy TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group